semaglutide and thyroid tumors Can Cause Issues? FDA Warnings Safety Facts No Increased Risk for Thyroid

Asked a few weeks ago by this newspaper about the medications approximate launch date in Spain, Francisco Pajuelo, Novo Nordisks medical director in Spain, declined to specify a date and commented that the drug shortages will continue throughout 2023. Sign up for our weekly newsletter to get more English-language news coverage from EL PAS USA Edition

When a term becomes popular before it becomes medically precise, patients can be left with the impression that a trend is more established than it really is

These drugs, part of the GLP-1 class, were developed to help manage type 2 diabetes

This can be harmful or prevent the drug from working well